ADVB
Price
$2.18
Change
+$0.14 (+6.86%)
Updated
Nov 3, 03:16 PM (EDT)
Capitalization
3.37M
15 days until earnings call
Intraday BUY SELL Signals
QUCY
Price
$0.72
Change
-$0.04 (-5.26%)
Updated
Nov 3, 04:09 PM (EDT)
Capitalization
63.83M
10 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADVB vs QUCY

ADVB vs QUCY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADVB vs. QUCY commentary
Nov 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVB is a Hold and QUCY is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ADVB with price predictions
Nov 02, 2026

ADVB in -22.73% downward trend, declining for three consecutive days on November 02, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ADVB declined for three days, in 111 of 115 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ADVB as a result. In 31 of 35 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

The Aroon Indicator for ADVB entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

ADVB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.207) is normal, around the industry mean (65.876). P/E Ratio (1.688) is within average values for comparable stocks, (3.542). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (9.775).

The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. ADVB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADVB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

A.I.Advisor
a Summary for QUCY with price predictions
Nov 02, 2026

Momentum Indicator for QUCY turns negative, indicating new downward trend

QUCY saw its Momentum Indicator move below the 0 level on October 09, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 109 similar instances where the indicator turned negative. In 100 of the 109 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for QUCY turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 37 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

QUCY moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QUCY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for QUCY entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for QUCY's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +12.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where QUCY advanced for three days, in 152 of 187 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

QUCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. QUCY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.144) is normal, around the industry mean (65.876). P/E Ratio (-0.472) is within average values for comparable stocks, (3.542). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. QUCY's P/S Ratio (60.976) is very high in comparison to the industry average of (9.775).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QUCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
ADVBQUCY
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 03, 2026
Stock price -- (ADVB: $2.04 vs. QUCY: $0.76)
Brand notoriety: ADVB and QUCY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ADVB: 17% vs. QUCY: 78%
Market capitalization -- ADVB: $3.37M vs. QUCY: $63.83M
ADVB [@Medical Specialties] is valued at $3.37M. QUCY’s [@Medical Specialties] market capitalization is $63.83M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical Specialties] industry is $21.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVB’s FA Score shows that 0 FA rating(s) are green while QUCY’s FA Score has 1 green FA rating(s).

  • ADVB’s FA Score: 0 green, 5 red.
  • QUCY’s FA Score: 1 green, 4 red.
According to our system of comparison, QUCY is a better buy in the long-term than ADVB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVB’s TA Score shows that 3 TA indicator(s) are bullish while QUCY’s TA Score has 4 bullish TA indicator(s).

  • ADVB’s TA Score: 3 bullish, 3 bearish.
  • QUCY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ADVB is a better buy in the short-term than QUCY.

Price Growth

ADVB (@Medical Specialties) experienced а -27.92% price change this week, while QUCY (@Medical Specialties) price change was -10.83% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.47%. For the same industry, the average monthly price growth was -4.50%, and the average quarterly price growth was +42.79%.

Reported Earning Dates

ADVB is expected to report earnings on Nov 18, 2026.

QUCY is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Medical Specialties (-1.47% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
ADVB
Daily Signal:
Gain/Loss:
QUCY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ADVB and

Correlation & Price change

A.I.dvisor tells us that ADVB and QUCY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADVB and QUCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVB
1D Price
Change %
ADVB100%
-11.30%
QUCY - ADVB
22%
Poorly correlated
-9.61%
OPK - ADVB
22%
Poorly correlated
+3.61%
XGN - ADVB
22%
Poorly correlated
-2.33%
BIAF - ADVB
3%
Poorly correlated
+2.75%
GRAL - ADVB
3%
Poorly correlated
-6.74%
More

QUCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, QUCY has been loosely correlated with ACRS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if QUCY jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QUCY
1D Price
Change %
QUCY100%
-9.61%
ACRS - QUCY
41%
Loosely correlated
-4.28%
STXS - QUCY
27%
Poorly correlated
+2.03%
ILMN - QUCY
25%
Poorly correlated
-3.99%
GH - QUCY
24%
Poorly correlated
-4.51%
ADVB - QUCY
23%
Poorly correlated
-11.30%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALA0.17N/A
+2.60%
Kala Bio Inc
VIOT1.30N/A
N/A
Viomi Technology Co Ltd
LOGI94.55-0.98
-1.03%
Logitech International SA
ASAN11.06-0.17
-1.51%
Asana
BLDP1.50-0.07
-4.46%
Ballard Power Systems